Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on July 8, 2025
Gordon Brothers Agents C$200M in Financing to Support Morgan Construction’s New Equipment Purchases & Growth
GlobeNewswire
·
July 8, 2025
Boston, July 08, 2025 (GLOBE NEWSWIRE) -- Gordon Brothers, the global asset experts, has agented C$200 million in financing, consisting of a five-year C$150 million revolving credit facility and a C$50 million accordion, to support Morgan Construction’s …
Thrive Acquires GRC-Focused Abacode
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Thrive, a global technology outsourcing provider for cybersecurity, Cloud, and IT managed services, today announced the acquisition of Abacode, a leading Managed Cybersecurity …
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
GlobeNewswire
·
July 8, 2025
HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced its participation in the inaugural Endovascular Robotics session at the Society of Robotic …
Almond FinTech Expands Its Transfer Network in APAC through Ample Transfers Partnership
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Almond FinTech, the two-time CrossTech Innovation Award winner for "Crypto Payments Solution in Cross-Border Payments," announced today that Ample Transfers, a 27-year-old remittance provider based in Singapore, …
Liberty Announces C$3.75 Million Private Placement of Units
GlobeNewswire
·
July 8, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia and WILMINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE:E30 …
DemandScience Launches Digital Audiences for Multi-Channel Account- and Persona-Based Targeting
GlobeNewswire
·
July 8, 2025
DANVERS, MA, July 08, 2025 (GLOBE NEWSWIRE) -- Danvers, MA – July 08, 2025 – DemandScience, a leader in B2B tech-enabled revenue marketing solutions, today announced the launch of Digital Audiences, a new audience activation solution that brings together …
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 25th Annual Summer Conference
GlobeNewswire
·
July 8, 2025
NEWBURYPORT, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Mitchell Rock, President, and Ron Lataille, Sr. Vice President …
Coralogix Signs Strategic Collaboration Agreement with AWS to Advance AI-Powered Observability and Security
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Coralogix, a leading full-stack observability platform provider, today announced a strategic collaboration agreement (SCA) with Amazon Web Services (AWS). Through this collaboration, Coralogix and AWS will create …
Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
GlobeNewswire
·
July 8, 2025
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Nik Grund, Chief Commercial Officer, …
MariMed Announces Second Quarter 2025 Earnings Date
GlobeNewswire
·
July 8, 2025
NORWOOD, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report second quarter 2025 financial results on …
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
GlobeNewswire
·
July 8, 2025
Seasoned Leader Brings Deep Experience in Oncology Drug Development as Company Advances Portfolio of Next Generation Therapeutics for Solid Tumors WALTHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) ( …
Diagonal Therapeutics Appoints John Lee, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire
·
July 8, 2025
Biotech veteran will lead clinical development of Diagonal’s clustering antibody pipeline, including DIAG723 for hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH) WATERTOWN, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- …
Mercury Receives Two New Common Processing Architecture Production Awards
GlobeNewswire
·
July 8, 2025
ANDOVER, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing to the edge, today announced it received two new production awards in June totaling $36.9 …
CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced it will deliver Developing Topics (late-breaking) virtual and in-person …
Agios Appoints Dr. Jay Backstrom to Board of Directors
GlobeNewswire
·
July 8, 2025
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the appointment of Jay Backstrom, M. …
Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
GlobeNewswire
·
July 8, 2025
– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for verekitug into third indication, strengthening pipeline …
Jade Biosciences to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
July 8, 2025
SAN FRANCISCO and VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its …
Plymouth Industrial REIT Provides Activity Update for Second Quarter 2025
GlobeNewswire
·
July 8, 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company” or “Plymouth”) provided an activity update for the second quarter of 2025. The Company also announced details for its second quarter earnings conference …